Amishi Desai, MD

Articles by Amishi Desai, MD

Dr. Desai on Immunotherapy in Patients With NSCLC and Low PD-L1 Expression

December 18th 2018

Amishi Desai, MD, assistant professor of medicine at Upstate University Hospital, discusses the use of immunotherapy in patients with non–small cell lung cancer (NSCLC) with PD-L1 expression less than 1%.

Latest Updated Articles

Dr. Desai on Immunotherapy in Patients With NSCLC and Low PD-L1 Expression
Published: December 18th 2018 | Updated:

Amishi Desai, MD

Articles by Amishi Desai, MD

Dr. Desai on Immunotherapy in Patients With NSCLC and Low PD-L1 Expression

Latest Updated Articles

Trending on OncLive

Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma

Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma

FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL

Dr Riedell on the Long-Term Efficacy of Tisa-Cel in R/R Follicular Lymphoma

Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma